Matsubara H - Search Results

1

Comprehensive registry of esophageal cancer in Japan, 2012.

Tachimori Y, Ozawa S, Numasaki H, Ishihara R, Matsubara H, Muro K, Oyama T, Toh Y, Udagawa H, Uno T; Registration Committee for Esophageal Cancer of the Japan Esophageal Society. Tachimori Y, et al. Among authors: matsubara h. Esophagus. 2019 Jul;16(3):221-245. doi: 10.1007/s10388-019-00674-z. Epub 2019 May 16. Esophagus. 2019. PMID: 31098822 Free PMC article. No abstract available.

2

Treatment response and prognosis of patients after recurrence of esophageal cancer.

Shimada H, Kitabayashi H, Nabeya Y, Okazumi S, Matsubara H, Funami Y, Miyazawa Y, Shiratori T, Uno T, Itoh H, Ochiai T. Shimada H, et al. Among authors: matsubara h. Surgery. 2003 Jan;133(1):24-31. doi: 10.1067/msy.2003.31. Surgery. 2003. PMID: 12563234

3

[Progress of gene therapy for esophageal cancer in Japan].

Matsubara H, Ochiai T. Matsubara H, et al. Gan To Kagaku Ryoho. 2003 Jul;30(7):944-9. Gan To Kagaku Ryoho. 2003. PMID: 12894708 Review. Japanese.

4

Surgical outcome of patients with thoracic esophageal cancer positive for cervical lymph nodes.

Shimada H, Shiratori T, Okazumi S, Matsubara H, Nabeya Y, Shuto K, Shimizu T, Hayashi H, Ochiai T. Shimada H, et al. Among authors: matsubara h. Hepatogastroenterology. 2007 Jan-Feb;54(73):100-3. Hepatogastroenterology. 2007. PMID: 17419240

5

[Reinitiation of database registration of patients of esophageal neoplasm in Japan].

Ozawa S, Hizuki Y, Tanaka O, Shinoda M, Udagawa S, Matsubara H, Baba H, Takeuchi Y, Koyama T, Muro K, Uno T, Tejima S, Numasaki H, Yamana H, Konishi T. Ozawa S, et al. Among authors: matsubara h. Gan To Kagaku Ryoho. 2008 Sep;35(9):1497-9. Gan To Kagaku Ryoho. 2008. PMID: 18831088 Japanese. No abstract available.

6

Clinical and pathologic evaluation of the effectiveness of neoadjuvant chemoradiation therapy in advanced esophageal cancer patients.

Akutsu Y, Matsubara H, Shuto K, Uesato M, Mori M, Hoshino I, Shiratori T, Miyazawa Y, Ito H, Uno T. Akutsu Y, et al. Among authors: matsubara h. World J Surg. 2009 May;33(5):1002-9. doi: 10.1007/s00268-008-9899-8. World J Surg. 2009. PMID: 19247705

7

The number of pathologic lymph nodes involved is still a significant prognostic factor even after neoadjuvant chemoradiotherapy in esophageal squamous cell carcinoma.

Akutsu Y, Shuto K, Kono T, Uesato M, Hoshino I, Shiratori T, Isozaki Y, Akanuma N, Uno T, Matsubara H. Akutsu Y, et al. Among authors: matsubara h. J Surg Oncol. 2012 Jun 15;105(8):756-60. doi: 10.1002/jso.23007. Epub 2011 Dec 12. J Surg Oncol. 2012. PMID: 22162007

8

[Treatment strategy for thoracic esophageal cancer].

Matsubara H. Matsubara H. Nihon Rinsho. 2011 Aug;69 Suppl 6:218-22. Nihon Rinsho. 2011. PMID: 22471020 Review. Japanese. No abstract available.

9

[Heavy ion radiotherapy for esophageal cancer].

Akutsu Y, Matsubara H. Akutsu Y, et al. Among authors: matsubara h. Nihon Rinsho. 2011 Aug;69 Suppl 6:358-62. Nihon Rinsho. 2011. PMID: 22471044 Japanese. No abstract available.

10

Lymph node dissection for esophageal cancer.

Akutsu Y, Matsubara H. Akutsu Y, et al. Among authors: matsubara h. Gen Thorac Cardiovasc Surg. 2013 Jul;61(7):397-401. doi: 10.1007/s11748-013-0237-1. Epub 2013 Mar 26. Gen Thorac Cardiovasc Surg. 2013. PMID: 23529259 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,027 results

Search Page